Resistin 420C/G gene polymorphism on circulating resistin, metabolic risk factors and insulin resistance in adult women

Immunology Letters

Volumn 162, Issue 2, 2014, Pages 287-291

  Kumar, Sandeep ^a,e   Gupta, Vani ^a   Srivastava, Nidhi ^a   Gupta, Vandana ^b   Mishra, Sameeksha ^a   Mishra, Supriya ^a   Natu Shankar, Madhav ^a   Roy, Uma ^c   Chandra, Abhijit ^a   Negi, M P S ^d  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b REGIONAL INSTITUTE OF MEDICAL SCIENCES   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d Institute for Data Computing and Training   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Insulin resistance; Metabolic syndrome; Resistin level; Resistin promoter gene polymorphism

Indexed keywords

GLUCOSE; INSULIN; RESISTIN; TRIACYLGLYCEROL; RETN PROTEIN, HUMAN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OBESITY; PROMOTER REGION; RESISTIN GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; ALLELE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; GENETICS; IMMUNOLOGY; METABOLIC SYNDROME X; RISK FACTOR;

ADULT; ALLELES; ATHEROSCLEROSIS; BLOOD PRESSURE; FEMALE; HUMANS; METABOLIC SYNDROME X; OBESITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; RESISTIN; RISK FACTORS; TRIGLYCERIDES;

EID: 84913591144     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.07.009     Document Type: Article

References (40)

1. Nogueiras R., Novelle M.G., Vazquez M.J., Lopez M., Dieguez C. Resistin: regulation of food intake, glucose homeostasis and lipid metabolism. Endocr Dev 2010, 17:175-184.
2. McTernan C.L., McTernan P.G., Harte A.L., Levick P.L., Barnett A.H., Kumar S. Resistin central obesity and type 2 diabetes. Lancet 2002, 359:46-47.
3. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
4. Chen B.H., Song, Y, Ding E.L., Roberts C.K., Manson J.E., Rifai N., et al. Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care 2009, 32:329-334.
5. Momiyama Y., Ohmori R., Uto-Kondo H., Tanaka N., Kato R., Taniguchi H., et al. Serum resistin levels and cardiovascular events in patients under-going percutaneous coronary intervention. J Atheroscler Thromb 2011, 18(2):108-114.
6. Wang H., Chu W.S., Hemphill C., Elbein S.C. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocr Metab 2002, 87:2520-2524.
7. Holcomb I.N., Kabakoff R.C., Chan B., Baker T.W., Gurney A., Henzel W., et al. A novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000, 19:4046-4055.
8. Kawashima J., Tsuruzoe K., Motoshima H., Shirakami A., Sakai K., Hirashima Y., Toyonaga T., et al. Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003, 2:231-240.
9. Shojima N., Sakoda H., Ogihara T., Fujishiro M., Katagiri H., Anai M., et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002, 6:1737-1744.
10. Delhanty P.J., Mesotten D., McDougall F., Baxter R.C. Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (SDR) rats. Endocrinology 2002, 6:2445-2448.
11. Juan C.C., Au L.C., Fang V.S., Kang S.F., Ko Y.H., Kuo S.F., et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001, 289:1328-1333.
12. Le Lay S., Boucher J., Rey A., Castan-Laurell I., Krief S., Ferré P., et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 2001, 289:564-567.
13. Way J.M., Görgün C.Z., Tong Q., Uysal K.T., Brown K.K., Harrington W.W., et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator activated receptor gamma agonists. J. Biol Chem 2001, 276:25651-25653.
14. Ukkola O. Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?. Eur J Endocrinol 2002, 147:571-574.
15. Sheng C.H., Di J., Jin Y., Zhang Y.C., Wu M., Sun Y., et al. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008, 33:135-143.
16. Aquilante C.L., Kosmiski L.A., Knutsen S.D., Zineh I. Relationship between plasma resistin concentrations, inflammatory chemokines, components of the metabolic syndrome in adults. Metab Clin Exp 2008, 4:494-501.
17. Menzaghi C., Coco A., Salvemini L., Thompson R., De Cosmo S., Doria A., et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 2006, 7:2792-2795.
18. Wasim H., Al-Daghri N.M., Chetty R., McTernan P.G., Barnett A.H., Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol 2006, 2:5-10.
19. Burnett M.S., Devaney J.M., Adenika R.J., Lindsay R., Howard B.V. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab 2006, 1:64-68.
20. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003, 11:5452-5455.
21. Kunnari A., Ukkola O., Kesaniemi Y.A. Resistin polymorphisms are associated with cerebrovascular disease in Finnish type 2 diabetic patients. Diabet Med 2005, 5:583-589.
22. Heilbronn L.K., Rood J., Janderova L., Albu J.B., Kelley D.E., Ravussin E., et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004, 4:1844-1848.
23. Pagano C., Marin O., Calcagno A., Schiappelli P., Pilon C., Milan G., et al. Increased plasma resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005, 90:4335-4340.
24. Matsuda M., Kawasaki F., Yamada K., Kanda Y., Saito M., Eto M., et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med 2004, 21:881-888.
25. Farvid M.S., Ng T.W., Chan D.C., Barrett P.H., Watts G.F. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005, 7:406-413.
26. Utzschneider K.M., Carr D.B., Tong J., Wallace T.M., Hull R.L., Zraika S., et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005, 48:2330-2333.
27. Zou C.C., Liang L., Hong F., Fu J.F., Zhao Z.Y. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J 2005, 52:519-524.
28. Cho Y.M., Youn B.S., Chung S.S., Kim K.W., Lee H.K., Yu K.Y., et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004, 47:559-565.
29. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
30. Keskin M., Kurtoglu S., Kendirci M., Atabek M.E., Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005, 115(4):500-503.
31. Bouchard L., Weisnagel S.J., Engert J.C., Hudson T.J., Bouchard C., Vohl M.C., et al. Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J Endocrinol Invest 2004, 27:1003-1009.
32. Mattevi V.S., Zembrzuski V.M., Hutz M.H. A resistin gene polymorphism is associated with body mass index in women. Hum Genet 2004, 115:208-212.
33. Asano H., Izawa H., Nagata K., Nakatochi M., Kobayashi M., Hirashiki A., et al. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2010, 53:234-246.
34. Osawa H., Tabara Y., Kawamoto R., Ohashi J., Ochi M., Onuma H., et al. Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 2007, 30:1501-1506.
35. Bik W., Ostrowski J., Baranowska-Bik A., Wolinska-Witort E., Bialkowska M., Martynska L., et al. Adipokines and genetic factors in overweight or obese but metabolically healthy polish women. Neuro Endocrinol Lett 2010, 31(4):497-506.
36. Osawa H., Tabara Y., Ohashi J., Kawamura R., Onuma H., Makino H. Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?. Diabetologia 2010, 53:795-797.
37. Chung S.S., Choi H.H., Kim K.W., Cho Y.M., Lee H.K., Park K.S., et al. Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site. Diabetologia 2005, 48:1150-1158.
38. Chen C.C., Li T.C., Li C.I., Liu C.S., Wang H.J., Lin C.C. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005, 54:471-475.
39. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., Veves A. Circulating adiponectin and resistin levels in elation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-2457.
40. Sato N., Kobayashi K., Inoguchi T., Sonoda N., Imamura M., Sekiguchi N., et al. Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology 2005, 146:273-279.